What is Anixa Biosciences Inc?
, a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 84.82M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 10105,536 shares $292k |
| 3-6months | 0 | 1064,821 shares $200k |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |